Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Gross Profit: 2018-2024

Historic Gross Profit for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $458.8 million.

  • CureVac N.V's Gross Profit rose 96.13% to -$1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $531.2 million, marking a year-over-year increase of 620.77%. This contributed to the annual value of $458.8 million for FY2024, which is 703.93% up from last year.
  • CureVac N.V's Gross Profit amounted to $458.8 million in FY2024, which was up 703.93% from -$76.0 million recorded in FY2023.
  • CureVac N.V's 5-year Gross Profit high stood at $458.8 million for FY2024, and its period low was -$154.7 million during FY2021.
  • Its 3-year average for Gross Profit is $88.0 million, with a median of -$76.0 million in 2023.
  • Its Gross Profit has fluctuated over the past 5 years, first slumped by 473.87% in 2021, then skyrocketed by 703.93% in 2024.
  • Over the past 5 years, CureVac N.V's Gross Profit (Yearly) stood at $41.4 million in 2020, then plummeted by 473.87% to -$154.7 million in 2021, then increased by 23.11% to -$118.9 million in 2022, then surged by 36.12% to -$76.0 million in 2023, then soared by 703.93% to $458.8 million in 2024.